You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 23, June 16, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Health Agencies Update
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Spare the Liver

Joan Stephenson

JAMA. 1999;281:2175.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Conventional wisdom holds that when the body is infected with hepatitis B virus (HBV), the severe liver damage suffered by some patients is caused by cytotoxic T cells that seek out and destroy infected liver cells. Now, however, new research by National Institute of Allergy and Infectious Disease (NIAID) scientists and grantees suggests that the immune system usually succeeds in purging most of the virus from the body by interfering with HBV's ability to reproduce—a gentler, liver-sparing strategy (Science. 1999;284:825-829).

The investigators found that more than 90% of HBV in chimps infected with the virus was eliminated before the immune system had mobilized cytotoxic T cells against infected liver cells. As a result, relatively few HBV-infected hepatocytes remained as tempting targets for immune system attack.

The finding of an anti-HBV mechanism independent of cytotoxic T cells may help explain why only some individuals infected with HBV—those with . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.